BMJ open respiratory research
Journal
Overview
publication venue for
-
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial..
12.
2025
-
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities..
12.
2025
-
Patient perspectives on knowledge gaps in hypersensitivity pneumonitis..
11.
2024
-
Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey..
10.
2023
-
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)..
10.
2023
-
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)..
10.
2023
-
Is it time to include oxygen needs as an endpoint in clinical trials in patients with fibrosing interstitial lung disease? If so, how?.
10.
2023
-
Association of body mass index with morbidity in patients hospitalised with COVID-19..
8.
2021
-
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease..
7.
2020
-
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial..
6.
2019
-
'It's difficult, it's life changing what happens to you', patient perspective on life with chronic hypersensitivity pneumonitis: a qualitative study.
6.
2019
-
Differentiation of quantitative CT imaging phenotypes in asthma versus COPD..
4.
2017
-
Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study..
4.
2017
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)